Organigram Shares Q1 Fiscal 2019 Results

- January 28th, 2019

Organigram Holdings issued the financial and operational results for its Q1 fiscal 2019.

Organigram Holdings (TSXV:OGI) issued the financial and operational results for its Q1 fiscal 2019.

As quoted in the press release:

“The first quarter of 2019 is just the start of what we expect to be a year of tremendous growth,” said Greg Engel, the Company’s Chief Executive Officer. “We’ve always believed the Moncton Campus would be a competitive advantage for us being able to produce high-quality indoor-grown product at low cash cost of cultivation. Our first quarter results confirmed that as we reported an adjusted gross margin of 71 [percent].”

The Company’s net revenue for the quarter was limited by post-harvest (extraction, packaging, excising and labelling) capabilities which it aggressively looks to augment and gain greater efficiencies on.

Select Highlights for the First Quarter of Fiscal 2019

  • The Company is proud to report record net sales from continuing operations for the three months ended November 30, 2018 (Q1’2019) of $12.4 million, up 419 [percent] from $2.4 million in Q1’2018, and up 287 [percent] from $3.2 million in Q4’2018.
  • Gross margin increased to $51.7 million in Q1’2019 from $1.3 million in Q1’2018 and $32.5 million in Q4’2018. Excluding fair value adjustments on biological assets (“adjusted gross margin”) these figures would be $8.8 million$0.6 million, and $1.6 million, respectively.

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *